ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1356	National Cancer Institute	Html	en	Carcinoma of Unknown Primary Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of metastatic cancer that has spread from an unidentified primary tumor.	general cancer information 0.411851 treatment 0.656267 cancer treatment 0.493001 breast cancer cells 0.486603 primary cancer 0.600191 new cancer treatments 0.408458 Peritoneal Cancer Treatment 0.426103 cancer cells 0.712358 tissue 0.443805 malignant tumor cells 0.423112 body 0.560831 type 0.447878 Cancer Information Service 0.414189 Squamous Neck Cancer 0.400297 PDQ cancer information 0.512966 clinical trial search 0.39505 treatment clinical trials 0.437756 certain changes 0.407705 National Cancer Institute 0.54586 clinical trials 0.823063 normal cells 0.410928 cancer information summary 0.471688 clinical trial 0.588388 new treatment 0.44726	breast cancer prevention 0.400005 primary cancer site 0.517081 cancer tissue 0.403216 patients 0.429603 Cancer Care page 0.397493 PDQ summary 0.435669 treatment clinical trial 0.401935 PDQ Adult Treatment 0.398071 NCI PDQ cancer 0.432436 cancer research process 0.400715 cancer clinical trials 0.44656 tests 0.388491 lymph nodes 0.409196 Unknown Primary Treatment 0.395812 carcinoma 0.39749 primary cancer depend 0.439856 lymph node 0.431668 radiation therapy 0.485838 Treatment Editorial Board 0.413559 cancer information summaries 0.411898 comprehensive cancer information 0.411754 cancer 0.945761 standard treatment 0.426236	CLICK HERE
1480	National Cancer Institute	Html	en	Gastric Cancer Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of gastric cancer.	median survival 0.63157 Three-year overall survival 0.637349 postoperative chemotherapy 0.607291 evidence 0.599884 S-1 group 0.532476 United States 0.629181 IIIB gastric cancer 0.571507 gastric cancer resection 0.57432 adjuvant chemoradiation therapy 0.846798 trial 0.61074 Postoperative chemoradiation therapy 0.558554 adjuvant combined modality 0.6554 total gastrectomy 0.60297 3-year OS rate 0.544309 3-year OS rates 0.626301 postoperative combined chemoradiation 0.551401 median follow-up 0.535007 therapy versus surgery 0.546551 chemoradiation therapy group 0.623893 significantly higher likelihood 0.622742 postoperative chemoradiation regimen 0.637796 noncardia gastric cancers 0.63288 surgery-only group 0.537222 relapse-free survival rates 0.794523	3-year OS 0.717532 gastroesophageal junction 0.570534 disease-free survival rate 0.550481 gastric cancer 0.998454 progression-free survival 0.57907 patients 0.884826 Neoadjuvant chemoradiation therapy 0.554541 metastatic gastric cancer 0.697572 curative intent 0.539619 significant survival benefit 0.6365 prospective multi-institution phase 0.543154 surgery-alone arm 0.607016 proximal subtotal gastrectomy 0.57677 perioperative chemotherapy group 0.806838 lymph nodes 0.576141 completely resected stage 0.638305 chemoradiation therapy 0.899775 hazard ratio 0.57654 regional lymph nodes 0.559708 Level 0.600335 chemoradiation therapy versus 0.543268 phase III trial 0.597716 3-year disease-free survival 0.564109	CLICK HERE
1663	National Cancer Institute	Html	en	Childhood Astrocytomas Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of childhood astrocytomas.	cancer treatment 0.624127 new cancer cells 0.50571 high-grade astrocytoma 0.568902 star-shaped brain cells 0.50361 metastatic brain tumors 0.515525 type 0.567046 tuberous sclerosis 0.508341 chemotherapy 0.51254 proton beam radiation 0.504515 PDQ cancer information 0.568694 clinical trial search 0.544652 brain tumors 0.664824 children 0.509721 new blood vessels 0.577461 dead tumor cells 0.517027 clinical trials 0.906249 cancer information summary 0.537035 clinical trial 0.760659 stem cell transplant 0.512502 treatment clinical trial 0.503103 radiation therapy 0.993729 Treatment Editorial Board 0.497213 beam radiation therapy 0.519746 subependymal giant cell 0.530817	treatment 0.904348 general information 0.532617 cancer cells 0.898737 conformal radiation therapy 0.568043 intensity-modulated radiation therapy 0.52166 specific cancer cells 0.501338 stereotactic radiation therapy 0.544315 childhood high-grade astrocytoma 0.500502 astrocytoma 0.619975 low-grade astrocytoma 0.590271 treatment clinical trials 0.531572 National Cancer Institute 0.535683 spinal cord 0.789593 effects cancer treatment 0.512031 new treatment 0.578461 external radiation therapy 0.577741 brain 0.729014 childhood astrocytoma 0.499108 cancer clinical trials 0.564469 checks tumor tissue 0.501876 tumor 0.802924 cancer 0.956922 information 0.571652 childhood low-grade astrocytoma 0.521596	CLICK HERE
1675	National Cancer Institute	Html	en	Lymphedema (PDQ®)–Health Professional Version	Expert-reviewed information summary about the anatomy, pathophysiology, clinical manifestations, diagnosis, and treatment of cancer-related lymphedema, a condition in which lymph fluid builds up in tissues and causes swelling.	upper-limb lymphedema 0.596897 Manual lymphatic therapy 0.494091 axillary node dissection 0.485114 lymph nodes. 0.472628 upper-extremity lymphedema 0.68666 arm lymphedema 0.638618 lower-limb lymphedema 0.630542 lymph node dissection 0.832229 lower-extremity lymphedema 0.630897 deep lymphatic systems 0.498654 intestinal lymphatic trunk 0.501781 new lymphedema 0.619269 lumbar lymphatic trunk 0.502509 upper extremity lymphedema 0.623186 manual lymphatic drainage 0.477215 lymph collector vessels 0.497637 lymphatic vessels 0.762836 lymphedema onset 0.622585 secondary lymphedema 0.644407 certified lymphedema 0.696216 left subclavian vein 0.475686 lymphedema manifest 0.633761 lymphedema classification 0.594846 protein-rich lymph fluid 0.533977	secondary lymphatic vessels 0.59679 subclavian lymphatic trunk 0.576658 primary lymphatic vessels 0.596665 subcutaneous lymphatic vessels 0.50703 lymphedema 0.987634 breast cancer patients 0.473019 certified lymphedema therapist 0.652056 patients 0.478875 cancer patients 0.474035 Lymph channels 0.46738 lymph node biopsy 0.634545 breast cancer 0.848001 sentinel lymph node 0.728941 certified lymphedema therapists 0.649954 unidirectional lymphatic flow 0.496065 breast cancer survivors 0.505056 axillary lymph node 0.799687 lymph nodes 0.59192 treatable lymphedema 0.590609 lymph node biopsy. 0.539242 manual lymphedema therapy. 0.64813 lymph node drainage 0.539621 manual lymphedema therapy 0.852751	CLICK HERE
1719	National Cancer Institute	Html	en	Sentinel Lymph Node Biopsy	A fact sheet that describes the sentinel lymph node biopsy procedure and details two clinical trials evaluating the effectiveness of this procedure.	breast cancer cells 0.207523 additional lymph nodes 0.324919 lymph node dissection 0.365902 cancer cells 0.313838 completion lymph node 0.32082 additional lymph node 0.319225 sentinel node 0.255614 clinical trials 0.22069 adjuvant systemic therapy 0.201592 nearby lymph nodes 0.410736 regional lymph node 0.311853 lymph vessels 0.353059 extensive lymph node 0.426951 lymph node removal 0.331582 sentinel lymph nodes 0.328406 external-beam radiation therapy 0.223044 positive sentinel lymph 0.331906	lymph node biopsy 0.364124 sentinel lymph node 0.877175 breast cancer 0.260519 negative axillary lymph 0.276414 fewer lymph nodes 0.321344 multiple lymph nodes 0.309038 SLNB 0.244263 lymph node involvement 0.373283 lymph fluid 0.290316 axillary lymph node 0.386593 lymph nodes 0.832406 additional nearby lymph 0.283578 lymph node 0.99204 lymph node surgery 0.535704 regional lymph nodes 0.405136 cancer 0.32073 lymph node metastasis 0.429092	CLICK HERE
1765	National Cancer Institute	Html	en	Physical Activity and Cancer	A fact sheet that summarizes evidence linking exercise and other physical activity, including work and household chores, to reduced cancer risks.	U. Physical activity 0.367372 bone-strengthening physical activity 0.370971 physical activity daily 0.371076 physical activity attenuate 0.362897 better breast cancer 0.3594 low physical activity 0.37763 Breast Cancer Research 0.357155 muscle-strengthening physical activity 0.370998 vigorous physical activity 0.364437 S. Physical activity 0.365821 average breast cancer 0.365315 cancer risk reduction 0.373439 colorectal cancer 0.41572 average endometrial cancer 0.357301 H. Physical activity 0.366033 postdiagnosis physical activity 0.363749 postmenopausal breast cancer 0.379275 lower risk 0.357009 potential physical activity 0.369413 physical activity influence 0.360893 different cancer risk 0.360424 aerobic physical activity 0.386234 vigorous-intensity physical activity 0.373987 cancer survivors 0.406644 Cancer Epidemiology 0.363652	cancer prevention 0.376861 Physical Activity website 0.371276 A. Physical activity 0.364619 breast cancer diagnosis 0.4205 endometrial cancer risk 0.390992 breast cancer recurrence 0.359315 Physical Activity Guidelines 0.371598 links physical activity 0.369787 physical activity benefit 0.375758 National Cancer Institute 0.363045 daily physical activity 0.370902 L. Physical activity 0.366831 breast cancer risk 0.390634 colon cancer 0.375643 meta-analysis 0.376142 breast cancer 0.54813 colon cancer risk 0.372667 systematic review 0.435657 physical activity 0.996162 prostate cancer 0.369869 leisure-time physical activity 0.442557 et al 0.539243 cancer risk 0.441434 recreational physical activity 0.391568	CLICK HERE
2068	National Cancer Institute	Html	es	Marcadores de tumores	Hoja informativa que explica lo que son los marcadores de tumores y responde preguntas sobre su uso para el diagnóstico y tratamiento del cáncer.	Bast RC Jr 0.727949 cancer screening 0.603977 Gray RJ 0.462067 randomized european study 0.51305 Asociación Estadounidense 0.468124 estudio plco 0.461327 Bigbee W 0.467579 amplia gama 0.464843 afecciones benignas 0.671952 Herberman RB 0.469893 Prevention Research 0.463207 BC Decker Inc 0.509079 Clinical Laboratory Improvement 0.519898 Cancer Screening Randomized 0.544857 Controlled Trial 0.467216 riesgo intermedio 0.462476 Clinical Practice 0.47196 ecografía transvaginal 0.471751 Makower DF 0.466396 estudio tailorx 0.460805 ¿Cuáles marcadores 0.637902 21-gene expression assay 0.514014	Hugosson J 0.463892 Instituto Nacional 0.461324 screening trial specimens 0.541412 Oncología Clínica 0.463202 tumor markers 0.619108 Andriole G 0.463781 Mortality results from 0.526447 Quality Requirements 0.470424 Kufe DW 0.468535 Black A 0.461077 6th ed 0.467056 Oncotype DX® 0.469566 situaciones benignas 0.492829 PubMed Abstract 0.928354 tratamientos resultantes 0.466203 Buys SS 0.460749 Bioquímica Clínica 0.461341 Pollock RE 0.46616 New England Journal 0.930005 Roobol MJ 0.466517 Sparano JA 0.466154 hoja informativa estadificación 0.539118	CLICK HERE
3582	National Cancer Institute	Html	en	Frederick National Laboratory for Cancer Research	The FNLCR combines private sector business practices with government infrastructure to conduct research and development in cancer and AIDS.	Frederick National Lab 0.679634 Development Center—one 0.586036 Federally Funded Research 0.723777 FNLCR 0.617129 biomarker identification 0.53533 animal sciences 0.53568 national resource 0.541398 government agencies 0.530109 human clinical trials 0.61809 preclinical assay development 0.712354 oncology-focused computational science 0.628628 cancer research laboratories 0.757218 early development 0.553877 research reagents 0.571396 NCI 0.666268 genetically engineered mouse 0.603734 preclinical research 0.638044 nonprofit research organizations 0.690454 broad charter 0.538883 Leidos Biomedical Research 0.735212 United States 0.647036 Nanotechnology Characterization Laboratory 0.625355 RAS family 0.527528 clinical practice 0.533965	NCI investigators 0.632716 significant cancer research 0.722685 translational genomics 0.544933 cancer research 0.952491 private sector business 0.653242 new drug development 0.647375 government sponsors 0.545164 biomedical research community 0.670235 development needs 0.584975 cancer researchers 0.562687 clinical operations 0.542191 Frederick National Laboratory 0.684108 government infrastructure 0.535486 technical staff 0.530406 preclinical model development 0.704349 private sector resources 0.635668 FNLCR programs 0.564698 National lab staff 0.628876 biomedical computing 0.548325 new cancer therapies 0.637914 frozen tumor samples 0.605424 nanotechnology applications 0.53469 cancer research enterprise 0.705608 basic research 0.59861	CLICK HERE
15637	National Cancer Institute	Html	null	Research Funding Mechanisms	The NCI uses grants, cooperative agreements, and contracts to help stimulate and fund cancer research.			CLICK HERE
16886	National Cancer Institute	Html	en	Thyroid Cancer Screening (PDQ®)–Health Professional Version	Expert-reviewed information summary about tests used to detect or screen for thyroid cancer.	thyroid cancer trends 0.476323 thyroid tumors 0.422645 United States 0.468063 thyroid cancer screening. 0.46539 cancer registry data 0.363099 thyroid fine-needle aspiration 0.447959 opportunistic thyroid cancer 0.46743 thyroid cancer 0.931034 thyroid cancer incidence 0.631162 Thyroid Cancer Treatment 0.500772 Well-differentiated thyroid cancers 0.495048 palpation screening results 0.370878 total thyroidectomy 0.358528 cancer screening results 0.386186 radioactive iodine 0.350234 South Korea 0.456219 10-year relative survival 0.451331 frequently diagnosed cancer 0.37852 recurrent laryngeal nerve 0.36801 papillary thyroid cancer 0.525506 summary event measure 0.364067 free screening exams 0.364504 follicular thyroid cancers 0.495803 thyroid cancer mortality 0.490522	thyroid cancer overdiagnosis 0.479797 neck palpation 0.364787 cancer incidence rates 0.389027 thyroid cancer deaths. 0.489306 thyroid cancers cases 0.461202 thyroid cancer cases 0.467037 papillary thyroid cancers 0.524728 cancer diagnoses 0.354076 anaplastic thyroid cancers 0.495303 laryngeal nerve injury 0.368292 thyroid cancer screening 0.828908 thyroid cancers 0.597668 thyroid ultrasound 0.428817 suspicious screening result 0.361018 thyroid surgery 0.435882 population-based screening programs 0.366887 national cancer screening 0.412147 medullary thyroid cancer 0.491568 Cancer Screening Guidelines 0.39228 formal screening 0.347128 asymptomatic thyroid cancers 0.481523 incidental thyroid nodules 0.466527 vocal cord 0.353855	CLICK HERE